EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Base editing of Artemis mutations ex vivo sheds light on gene therapy for Artemis-deficient SCID

Ziwen Huang, Zhenxi Cai, Peiyang Yan, Yiheng Hu, Ying Wang, Gaijing Zhou, Lisi Deng, Xinli Wang, Zhen Li, Weiting Chen, Xin Tao, Anlong Xu und 1 weitere

Advanced Biotechnology · 15.05.2026 · 4 (2)

DOI: 10.1007/s44307-026-00115-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biotechnology, online erschienen am 15.05.2026. Verfasst von Ziwen Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: SYSU Institute of Advanced Studies Hong Kong, Science Park, Hong Kong, 999077, People's Republic of China. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong S&T Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artemis is an endonuclease that cleaves DNA hairpins during V(D)J recombination, a critical step enabling coding-joint formation and essential for lymphocyte development. Artemis-deficient severe combined immunodeficiency (ART-SCID) is a monogenic disorder marked by impaired lymphocyte development and poor responsiveness to allogeneic hematopoietic stem cell transplantation. In this study, we explored the use of base editors to correct mutations in the Artemis gene. Specifically, we firstly documented the pathogenic mutations of Artemis from previous studies and newly identified from ClinVar database. Then, we performed ex vivo assays using cytidine base editors (CBEs) to repair the c.181T > C mutation, and adenosine base editors (ABEs) to target the pathogenic c.49G > A and c.404G > A variants associated with ART-SCID. Targeted deep sequencing revealed that rAPOBEC1-SpRY-HF1-BE4max achieved efficient editing (~ 50%) at the c.181T > C site, while ABE8e reached ~ 35% and ~ 20% editing efficiency at the c.49G > A and c.404G > A sites, respectively. Importantly, base editors restored Artemis endonuclease activity in a 293T Artemis −/− system, with no detectable off-target effects at the predicted sites as assessed by targeted deep sequencing. These findings provide proof-of-concept that base editing can correct ART-SCID-associated mutations, highlighting its potential for future therapeutic development.

Schlagwörter

Stichwörter der Autor:innen

ABEART-SCIDArtemisCBEGene editing

Autor:innen und Institutionen

  • SYSU Institute of Advanced Studies Hong Kong, Science Park, Hong Kong, 999077, People's Republic of China.
  • Guangdong Provincial Key Laboratory of Pharmaceutical Functional Genes, MOE Key Laboratory of Gene Function and Regulation, MOE Engineering Center of South China Sea Marine Biotechnology, State Key Laboratory of Biocont…
  • Conservation and Utilization Laboratory of Mountain Characteristic Resources in Guangdong Province, School of Life Sciences, Jiaying University, Meizhou, 514015, People's Republic of China.
  • School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat-Sen University, Shenzhen, 518107, People's Republic of China. taoxin8@mail.sysu.edu.cn.
  • SYSU Institute of Advanced Studies Hong Kong, Science Park, Hong Kong, 999077, People's Republic of China. lssxal@mail.sysu.edu.cn.

Förderung

  • Guangdong S&T Program
  • National Natural Science Foundation of China

Zitieren

APA

Huang, Z., Cai, Z., Yan, P., Hu, Y., Wang, Y., Zhou, G., Deng, L., Wang, X., Li, Z., Chen, W., Tao, X., Xu, A., & Yuan, S. (2026). Base editing of Artemis mutations ex vivo sheds light on gene therapy for Artemis-deficient SCID. Advanced Biotechnology, 4(2). https://doi.org/10.1007/s44307-026-00115-w

Vancouver

Huang Z, Cai Z, Yan P, Hu Y, Wang Y, Zhou G, et al. Base editing of Artemis mutations ex vivo sheds light on gene therapy for Artemis-deficient SCID. Advanced Biotechnology. 2026;4(2). doi:10.1007/s44307-026-00115-w

BibTeX
@article{Huang2026,
  author = {Huang, Ziwen and Cai, Zhenxi and Yan, Peiyang and Hu, Yiheng and Wang, Ying and Zhou, Gaijing and Deng, Lisi and Wang, Xinli and Li, Zhen and Chen, Weiting and Tao, Xin and Xu, Anlong and Yuan, Shaochun},
  title = {Base editing of Artemis mutations ex vivo sheds light on gene therapy for Artemis-deficient SCID},
  journal = {Advanced Biotechnology},
  year = {2026},
  volume = {4},
  number = {2},
  doi = {10.1007/s44307-026-00115-w}
}
Kostenlos starten →